XML 200 R159.htm IDEA: XBRL DOCUMENT v3.20.2
Loans Payable and Loans Payable to Related Parties (Details Narrative) (Brooklyn ImmunoTherapeutics, LLC) (10-K) - USD ($)
1 Months Ended 2 Months Ended 7 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Oct. 31, 2018
Dec. 31, 2018
Dec. 31, 2018
Jul. 31, 2018
Sep. 30, 2020
Sep. 30, 2019
Nov. 05, 2018
Dec. 31, 2019
Nov. 07, 2018
Dec. 31, 2017
Equity ownership, percentage               51.00%    
Brooklyn Immunotherapeutics, LLC [Member]                    
Cash   $ 6,325,431 $ 6,325,431   $ 3,055,012 $ 6,260,338   $ 5,014,819    
Interest payable   33,114 33,114   135,140     90,512    
Sale of notes                
Brooklyn Immunotherapeutics, LLC [Member] | Class A Units [Member]                    
Interest payable                 $ 1,516,346  
Shares issued for new issue, value         $ 5,024,313     8,218,762    
Brooklyn Immunotherapeutics, LLC [Member] | Predecessor [Member]                    
Cash             $ 250,296      
Shares issued for new issue, value       $ 31,731            
Equity ownership, percentage       80.00%            
Debt interest rate       14.50%            
Debt maturity date       Dec. 31, 2019            
Sale of notes             1,500,000      
Brooklyn Immunotherapeutics, LLC [Member] | Predecessor [Member] | Board of Directors [Member]                    
Shares issued for new issue, value       $ 11,095,368            
Brooklyn Immunotherapeutics, LLC [Member] | Predecessor [Member] | Predecessor Notes [Member]                    
Promissory notes       19,447,996            
Cash   15,165,816 15,165,816             $ 3,534,000
Interest payable       $ 716,449            
Interest expense             $ 1,652,466      
Brooklyn Immunotherapeutics, LLC [Member] | Predecessor [Member] | Bridge Notes [Member]                    
Interest expense $ 16,346                  
Sale of notes $ 1,500,000                  
Brooklyn Immunotherapeutics, LLC [Member] | Successor [Member]                    
Cash   6,325,431 6,325,431         5,014,819    
Loans payable   410,000 410,000              
Sale of notes                
Brooklyn Immunotherapeutics, LLC [Member] | Successor [Member] | Predecessor Notes [Member]                    
Interest expense     $ 9,121         $ 59,450